|
1.Azizi F، Post-transfusion hepatitis rate unknown. New Eng J Med 1971; 285:1321-2.
2. Azizi F, Vagenakis A, Reichlin S, Braverman L, Ingbar S: Persistent thyroregulatory dysfunction in rats made hyperthyroid at birth. Program of American Thyroid Association, 48th meeting, September 1972.
3. Azizi F, Vagenakis A, Corman A, Patch V, Samaraweera A, Braverman L, Ingbar: Depression of peripheral thyroxine turnover in heroin addicts. J Clin invest 1972; 51:7a.
4. Azizi F: Liver disease in addicts. Ann Int Med 1972; 76: 829-30.
5. Abreau C, Azizi F, Vagenakis A, Ingbar S, Braverman, LE: Clinical evaluation of a new method for indirectly measuring serum free T4 concentration. J Nucl Med 1973; 14: 159-63.
6. Azizi F, Castelli W, Pabon M, Mitchell M.: Effect of growth hormone on plasma triglycerides in man. Proc Soc Exp Biol 1973; 143: 1187-90.
7. Portnay GI, Abreau C, Azizi F, Vagenakis A, Braverman LE: A single test for measuring serum concentration of thyroxine (T4 (D)) and free thyroxine (FT4). Clinical Research 1973; 21: 500.
8. Abreau C, Vagenakis A, Azizi, F, Portnay GI, Braverman LE: A single method for measuring thyroxine and free thyroxine in serum. J Nucl Med 1973; 14: 740-6.
9. Azizi F, Braverman LE: Free thyroxine equivalent. Bul. IMA 1973; 4: 10-4.
10. Azizi F, Portnay GI, Vagenakis A, Rapoport B, Ingbar S, Braverman LE: Pituitary-thyroid response to intramuscular TRH. Clinical Research 1973; 21: 484.
11. Azizi F, Vagenakis A, Langcope C, Ingbar S, Braverman LE: Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 1973; 22: 467-72.
12. Vagenakis A, Azizi F, Portnay GI, Derideer J, Braverman LE, Ingbar S. Diminished TSH reserve following long term thyroid suppression. J Clin Invest 1973; 52: 85a.
13. Azizi F, Vagenakis A, Bollinger J, Ingbar S, Braverman LE: Functional response of pituitary and thyroid to a large dose of TRH in the rat. Program of the 55th Annual Meeting of Endocrine Society 1973; p 291.
14. Azizi F, Portnay GI, Vagenakis A, Ingbar S, Braverman LE: Pituitary-thyroid response to intramuscular TRH in man. Program of European Thyroid Association Meeting, September 1973.
15. Vagenkis A, Azizi F, Portnay GI, Deridder J, Braverman LE, Ingbar S: Diminished TSH reserve following long term thyroid suppression. Program of American Thyroid Association. 49th meeting, September 12-15, 1973; p T-2.
16. Portnay GO, Brien J, Bush JE, Vagenakis A, Azizi F, Arky RA, Ingbar S, Braverman LE: Effects of prolonged starvation on serum TSH, T4 and T3 concentration in man. Clinical Research 1973; 21: 958.
17. Azizi F, Vagenkis A, Bollinger J, Reichlin S, Braverman LE, Ingbar S: Persistent abnormalities in pituitary function following neonatal thyrotoxicosis in the rat. Endocrinology 1974; 94: 1681-88.
18. Azizi F, Vagenakis A, Portnay GI, Braverman LE, Ingbar S: Thyroxine transport and metabolism in methadone and heroin addicts. Ann Int Med 1974; 80: 194-9.
19. Azizi F, Vagenakis A, Bush J, Braverman LE: The effect of propranolol on various aspects of thyroid function in the rat. Metabolism 1974; 23: 525-9.
20. Azizi F, Chandler C, Bozorgzadeh H, Braverman LE: The occurrence of hyperthyroidism in patients with Downs' syndrome. Johns Hopkins Med J 1974; 134: 303-6.
21. Vagenakis A, Azizi F, Portnay GI, Braverman LE, Rapoport B, Ingbar S: Hyper-response to TRH accompanying small decreases in serum thyroid hormone concentrations. Clinical Research 1974; 22: 352a.
22. Azizi F, Bentley D, Vagenakis A, Portnay GI, Schwachman H, Ingbar S, Braverman LE: Abnormal thyroid function and the response to iodides in cystic fibrosis. Trans Assoc Am Physicians 1994; 87:111-9.
23. Azizi F: Agranulocytosis possibly induced by methaqualone. Ann Int Med 1974; 81: 268-9.
24. Vagenakis A, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar S: Hyper-response to thyrotropin releasing hormone (TRH) accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 1974; 53: 913-8.
25. Portnay GO, Brien J, Bush J, Vagenakis A, Azizi F, Arky RA, Ingbar S, Braverman LE: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and the response to TRH. J Clin Endo Metab 1974; 39: 191-4.
26. Azizi F, Vagenakis A, Portnay GI, Bust J, Braverman LE, Ingbar S: A reinvestigation of the effects of phenobarbital on thyroid hormone economy in the rat. Program of the 56th Annual Meeting of Endocrine Society, June, 1974.
27. Azizi F, Vagenakis A, Bollinger J, Braverman LE: The effect of a single large dose of thyrotropin-releasing hormone on various aspects of thyroid function in the rat. Endocrinology 1974; 95: 1767-70.
28. Azizi F, et al: Permanent alteration in rats treated with TRH during the neonatal period. Clin Research 1974; 22: 690A.
29. Azizi F, Bentley D, Vagenakis A, Portnay GI, Schwachman H, Ingbar S, Braverman LE: Abnormal thyroid function and the response to iodide in cystic fibrosis. Trans Assoc Am Phys 1974; 87: 111-9.
30. Azizi F: The treatment of Gaves' disease. JAMA 1974; 228: 976 (L).
31. Azizi F, Vagenakis A, Ingbar S, Braverman LE: The time course of changes in TRH responsiveness in man following a single dose of lio-thyronine. Metabolism 1974; 24: 691-4.
32. Azizi F, Vagenakis A, Portnay GI, Ingbar S, Braverman LE: Effect or a single oral dose of triiodothyronine on the subsequent response TRH on normal individuals. J Clin Endocrinol Metab 1975; 40: 157-9.
33. Azizi F, et al: Effects of diphenyl-hydantion on thyro-regulatory mechanism in the rat. Program of the 57th Annual Meeting of Endocrine Society, June 1975.
34. Azizi F, Vagenakis A, Portnay GI, Rapoport B, Ingbar S, Braverman LE: Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone (TRH) based on analyses of serum thyroxine, triiodothyronine and thyrotropin concentration. New Engl J Med 1975; 292: 273-7.
35. Azizi F, Vagenakis A, Braverman LE: The effect of intramuscular TRH on the thyroid 131I uptake in man. Johns Hopkins Med J 1975; 136: 11-4.
36. Azizi F, et al: Evaluation of radioimmunonassay method for measuring serum concentration of thyroxine. Clin. Research 1975; 23: 572a.
37. Vagenakis A, Burger A, Portnay GI, Rudolph M, O Brien J, Azizi F, Arky RA, Nicol P, Ingbar S, Braverman LE: Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endo Metab 1975; 141: 194.
38. Vagenakis A, Braverman LE, Azizi F, Potnay G, Ingbar S: Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid suppression therapy. N Engl J Med 1975; 293: 681-4.
39. Rogado A, Azizi F, Graham J: The heel of achilles. Headaches 1976; 15: 237-2.
40. Rosenthal D, Chandler H, Azizi F, Schneider P: Uptake of bone image agents by diffuse pulmonary metastatic calcification. A J Roentgenol 1977; 129: 871-4.
41. Sawin C, Chopra D, Albano J, Azizi F: The free T3 index. Ann Int Med 1978; 88: 474-7.
42. Azizi F: The effect of dietary composition on fasting induced changes in serum thyroid hormone and thyrotropin. Metabolism 1978; 27: 935-42.
43. Harris A, Fang S, Azizi F, Vagenakis A, Braverman LE: Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 1978; 27: 1074-83.
44. Azizi F, Belur R, Albano J: Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Int Med 1979; 90: 941-2.
45. Sawin CT, Chpora D, Azizi F, et al: The aging thyroid: Increased prevalence of elevated serum thyrotropin (TRH) in the elderly. J A M A 1979; 242: 247-50.
46. Azizi F, Mannix J, Nelson R: The effect of winter sleep on the pituitary thyroid axis in the American black bear. Am J Physiol 1979; 237: 227-E230.
47. Azizi F: Age related changes in pituitary and thyroid functions in the rat. AM J Physiol 1979; 237: E224-E226.
48. Theodoropoulos T, Fang SL, Azizi F, Ingbar SH, Vagenakis AG, Braverman LE: Effect of diphyenylhydantoin on hypothalamic-pituitary-thyroid function in the rat. Am J Physiol 1980; 239: E468-73.
49. Rhie FH, Ganda OP, Bern MM, Soeldner JS, Gerson B, Azizi F: Insulin resistance and monoclonal gammopathy. Metabolisn 1981; 30: 41-5.
50. Azizi F: Gamma-glutamyl trans-peptidase levels in thyroid disease. Arch Int Med 1982; 142: 79-81.
51. Azizi F, Lipinska I: High-density lipoprotein in thyroid disease. Proceedings of the second Asia and Oceania thyroid association meeting. Current Problems in Thyroid Research. Excerpta medica 1983; 605: 186.
52. Azizi F: Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goitre. J Clin Endocrinol Metab 1985; 61: 374-7.
53. Azizi F, Kimiagar M, Nafarabadi M, Mostafavi H: Goitre in Tehran and suburbs. Recent progress in thyroidology. Vichayanart A. et al. (ed.) Proceeding of the third Asia & Oceania Thyroid Association. Dec. 4-6, 1986, P. 388-91.
54. Azizi F: Unusual response to thionamide compounds in Tehran. Recent progress in thyroidology. Vichayanart A. et al. (ed). Proceedings of the third Asia and oceania thyroid Association. Dec. 4-6, 1986, 475-8.
55. Azizi F: Rasouli H: Serum glucose, bilirubin, calcium, phosphorus, protein and albumin concentrations during Ramadan. Med J IRI 1987; 1: 38-41.
56. Azizi F, Jalali N, Nafarabadi M: The effect of chemical weapons on serum concentrations of various hormones. Iran. J Med Sciences 1989; 4: 46-50.
57. Azizi F: Medical treatment of toxic goitre in an area of iodine deficiency. Med J IRI 1988; 2: 119-22.
58. Kimiagar M, Yassai MB, Nafarabadi M, Samami B, Azizi F: Endemic goitre in Boyer-Ahmad. Med J IRI 1989; 3: 27-9.
59. Azizi F: Response to antithyroids and ablation in 206 Patients with diffuse toxic goitre in an area of iodine deficiency. Lee M, et al (ed). Progress in thyroidology 1989. Proceedings of the 4th Asia and Oceania Thyroid Association meeting. Korea, 19-21. April 1989, P. 451-4.
60. Azizi F, Elyasi H, Sohrabpour H et al: Serum concentrations of various hormones following exposure to chemical weapons containing sulfur mustard. Med J IRI 1989; 3: 105-7.
61. Kimiagar M, Azizi F, Navai L, et al: Survey of iodine deficiency in a rural area near Tehran: Association of food intake and endemic goitre. Europ J Clin Nutr 1990; 44: 17-22.
62. Azizi F, Kimiagar M, Nafarabadi M, Yassai M: Current status of iodine deficiency disorders in the Islamic Republic of Iran. EMR Health Sery J 1990; 8: 23-7.
63. Azizi F، Amid MH: Clinical presentation of chemical warfare injuries in children and teenagers. Med J IRI 1990; 4: 103-8.
64. Azizi F، Elyasi H، Jalali N، Nafarabadi M: Transient decreased serum testosterone after exposure to mustard gas. Med J IRI 1990; 4: 191-5.
65. Azizi F: Serum levels of prolactin، thyrotropin، thyroid hormones، male reproductive function and TRH responsiveness in intermittent Islamic fasting. Med J IRI 1991; 5: 145-8.
66. Azizi F: Outcome of three forms of therapy for diffuse toxic goitre in an area of iodine deficiency. Iran J Med Sci 1991; 16: 104-11.
67. Azizi F: The effect of thyroxine therapy on the size of cold thyroid nodules in patients from an iodine-deficient area. Med J IRI 1992; 6: 161-5.
68. Azizi F: Environmental iodine affects clinical presentation and thyroid function in subacute thyroiditis. Iran J Med Sci 1992; 7: 93-9.
69. Azizi F, Amini M, Arbab P: Time course of changes in free thyroid indices, rT3, TSH, cortisol and ACTH following exposure to sulfur mustard. Experim & Clin Endocrinal 1993; 101: 303-6.
70. Azizi F, Sarshar A, Nafarabadi M, Ghazi A, Kimiagar M, Noohi S, Rahbar N, Bahrami A, Kalantari S: Impairment of neuromotor and cognitive development in iodine deficient school children with normal physical growth. Acta Endocr 1993; 129: 501-4.
71. Azizi F, Ghazi A, Nafarabadi M, Kimiagar M: Long-lasting normal serum TSH after withdrawal of thyroxine in hypothyroid subjects with iodine deficiency. IRJ Med sci 1993; 18: 123-7.
72. Azizi F, Nafarabadi M: Serum thyroid hormone concentration in healthy women during month of Ramadan. Emirates Med J 1994; 12: 140-3.
73. Azizi F, Keshavarz A, Roshanzamir F, Nafarabadi M: Reproductive function in men following exposure to chemical warfare containing sulfur mustard. Medicine & War 1995; 1134-44.
74. Azizi F, Kalani H, Kimiagar M, et al: Physical, neuromotor and intellectual impairment in non-cretinous school children with iodine deficiency. Int J Vit Nut Res 1995; 65: 199-205.
75. Azizi F: Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J pediatr 1996; 128: 855-9.
76. Azizi F, Katchoui A: Brucella infection of the thyroid gland. Thyroid 1996; 6: 461-3.
77. Azizi F, Kimiagar M, Ghazi A, et al: Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. Exp Clin Endocrinol & Diab 1996; 104: 387-91.
78. Azizi F: Medical aspects of Islamic fasting. Med J IRI 1996; 10: 241-6.
79. Azizi F: Diabetes mellitus in the Islamic Republic of Iran. IDF Bulletin 1996; 41: 38-9.
80. Azizi F, Kimiagar M, Ghazi A, et al: The effects of iodized oil injection in eu- and hypothyroid iodine deficient girls. J Endocrinal Invest 1997; 20: 18-23.
81. Azizi F: The reform of medical education in I.R.Iran. Med Edu 1997; 31: 159-62.
82. Navai L, Kimiagar M, Azizi F: Diabetes and IGT prevalence in Islamshar: Comparison of screening criteria. J Diab Assoc India 1999; 39: 9-14.
83. Azizi F, Khoshniat M, Bahrainian M, Hedayati M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000; 85: 3233-8.
84. Salarkia N, Azizi F, Kimiagar M, et al: L Monitoring iodine following consumption of iodized salt in Tehran inhabitants. Int J Vit Nutr Res 2000; 70: 65-9.
85. Azizi F: Research in medical education. J Iranian Medical Edu 2000; 2(1): 3-7.
86. Azizi F, Rahmani M, Majid M, et al: Tehran Lipid and Glucose Study (TLGS): Rationale and Design. CVD Prevention 2000; 3: 50-3.
87. Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1). J Soc Prev Med 2000; 77: 408-26.
88. Azizi F, Daftarian N: Side-effects of iodized oil administration in patients with simple goiter. J Endocrinol Invest 2001; 24: 72-7.
89. Azizi F, Afkhami M, Sarshar A, Nafarabadi M: Effects of transient neonatal hyperthyrotropinemia on intellectual quotient and psychomotor performance. Int J Vit Nut Res 2001; 71: 70-3.
90. Azizi F, Allahverdian S, Mirmiran P, Rahmani M, Mohammadi F: Dietary factors and body mass index in a group of Iranian adolescents. Tehran lipid and glucose study. Int J Vit Nut Res 2001; 71:123-7.
91. Azizi F, Rahmani M, Majid M, et al: Serum lipid levels in an Iranian population of children and adolescents: Tehran Lipid and Glucose Study. Europ J Epidemiol 2001; 17:281-8.
92. Shahbazian HB, Sarvghadi F, Azizi F: Prevalence and characteristics of postpartum thyroiditis in Tehran. Europ J Endocrinol 2001; 145: 397-401.
93. Azizi F, Rahmani M, Allahverdian S, Hedayati M. Effect of salted food consumption on urinary iodine and thyroid function tests in two provinces in the Islamic Republic of Iran. Eastern Mederranean Health J, 2001; 7: 115-120.
94. Azizi F, Delshad H, Mehrabi Y: Thyroid volume in schoolchildren of Tehran: Comparison with European schoolchildren. J Endocrinol Invest 2001; 24: 756-62.
95. Hedayati M, Yazdanparast R, Azizi F: Determination of human tumor necrosis factor by a highly sensitive enzyme immunoassay. Biochem Biophys Res Commun 2001; 289: 295-8.
96. Azizi F: Published researches in medical education in Iran. Iranian J Med Edu 2001; 1: 3-7.
97. Azizi F: Continuing professional development in health sector. Iranian J Med Edu 2001; 1: 53-63.
98. Houssaini SJ, Aslani A, Azizi F, et al: An evaluating of a continuing medical education program on the treatment of urinary stone. Iranian J Med Edu 2001; 1: 64-9.
99. Azizi F: IDD in the middle east. IDD Newsletter 2001; 17: 33-9.
100. Azizi F, Delshad H, Mehrabi Y: Thyroid volumes in schoolchildren of Tehran: Comparison with Eurpoean schoolchildren. J Endocrinol Invest 2001; 24: 756-62.
101. Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F: Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Altherosclerosis 2002; 162: 381-9.
102. Azizi F, Rahmani M, Raiszadeh F, et al: Association of lipid, lipoproteins, apolipoproteins, and paroxonase enzyme activity with premature coronary artery disease. Coronary Artery Disease 2002; 13: 9-16.
103. Azizi F, Sheikholeslam R, Hedayati M, et al: Sustainable control of iodine deficiency in Iran. J Endocrinol Invest 2002; 25: 409-13.
104. Azizi F, Hedayati M: Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 2002; 25: 493-6.
105. Azizi F, Khamseh ME, Bahreynian M, Hedayati M: Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 2002; 25: 586-9.
106. Azizi F, Ainy E, Mirmiran P, Habibian S: Contrceptive methods and risk factors of cardivascular diseases in Terhanian women: Tehran Lipid and Glucose Study. Europ J Contracep Reprodu Health Care 2002; 7: 1-6.
107. Khamseh ME, Mollanai S, Hashemi R, Rezaizadeh A, Azizi F: Erdheim-Chester syndrom; presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002; 25: 727-9.
108. Azizi F, Ghanbarian A, Majid M, Rahmani M: Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study, 1999-2000. J Hum Hypertension 2002; 16: 305-12.
109. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, Hajipour R. Determinants of serum HDL-C level in Tehran urban population: Tehran Lipid and Glucose Study. Nutr Metabol Cardiovas Dis 2002; 12: 80-9.
110. Azizi F, Navai L, Fattahi F: Monitoring of goiter, urinary iodine, thyroid function and antibodies, 12 years following iodine suplementation. Int J Vit Nut Res 2002; 72: 291-5.
111. Azizi F. Developing a training course on monitoring and evaluation. IDD Newsletter 2002; 18: 26-7.
112. Azizi F, Mirmiran P, Sheikholeslam R, Hedayati M, Rastmanesh R. The relation between ferritin and goiter, urinary iodine and thyroid hormone concentration. Int J Vit Nutr Res 2002; 72: 296-9.
113. Delange F, de Benoist B, Burgi H, Azizi F, Hajipour R, Bnemiloud M, et al: Determining median uprinary iodine concentration that indicates adequate iodine intake at population level. Bull WHO 2002; 80: 633-6.
114. Mirmiran P, Mirblooki M, Azizi F: Familial clustering of obesity and the role of nutrition: Tehran Lipid and Glucose Study. Int J Obes Relat Metab Disord 2002; 26: 1617-22.
115. Mirmiran P, Kimiagar M, Azizi F: Three-year survey of effects of iodized oil injection in schoolchildren with iodine deficiency disorders. Exp Clin Endocrinol Diab 2002; 110: 393-7.
116. Azizi F: Research in Islamic fasting and health. Ann Saudi Med 2002; 3-4: 186-91.
117. Azizi F, Rahmani M, Emami H, et al: Cardiovasular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study. J Soc Prev Med 2002; 47: 408-26.
118. Azizi F, Navai L, Fatahi F. Goiter prevalence, urinary iodine excretion, thyroid function and anti-thyroid antibodies after 12 years of salt iodization in Shhriar, Iran. Int J Vit Nutr Res 2002; 72: 291-5.
119. Mirmiran P, Mohammadi F, Allahverdian S, Azizi F: Association of educational level and marital status with dietary intake and cardiovascular risk factors in Tehranian adults: Tehran Lipid and Glucose Study (TLGS). Nutr Res 2002; 22: 1365-75.
120. Ordookhani A, Mirmiran P, Hajipour R, Azizi F: Screening of congenital hypothyroidism in Iran: Strategies, Obstacles and future prospectives. East Medit Heal J 2002; 8:480-9.
121. Azizi F, ِAiny E: Coronary health disease risk factors and menopause: A study in 2000 Tehranian women. Tehran Lipid and Glucose Study. Climacteric 2003; 6: 330-6.
122. Mirmiran P, Mohammadi F, Sarbazi N, Allahverdian S, Azizi F. Gender defferences in dietary intakes, anthripometrical measurements and biochemical indioes in an urban adult population: Tehran Lipid and Glucose Study. Nut Metab Cardiovas Dis 2003; 13: 64-71.
123. Azizi F, Malik M, Bebars E, Delshad H, Bakir A: Thyroid volume in schoolchildren of Emirates. J Endocrinol Invest 2003; 26:56-60.
124. Azizi F, Aminorroya A, Hedayati M, Rezvanian H, Amini M, Mirmiran P. Urinary iodine excretion in pregnant women residing in areas with adequate iodine intake. Publ Health Nutr 2003; 6: 95-8.
125. Azizi F, Emami H, Salehi P, Ghanbarian A, Mirmiran P, Heydarian P. Cardiovascular risk factors in elderly: Tehran Lipid and Glucose Study. J Cardiovasc Risk 2003; 10: 65-7.
126. Azizi F, Rashidi A, Ghanbarian A, Majid M: Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adults population? Tehran Lipid and Glucose Study (TLGS). Hum Hyperten 2003; 17: 287-91.
127. Mirmiran P, Hajipour R, Azizi F: Iodized salt consumption maintains euthyroidism in iodine deficient hypothyroid subject. J Vit Nutr Res 2003; 73: 187-91.
128. Mirmiran P, Mohammadi F, Allahverdian S, Azizi F: Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. J Vit Nutr Res 2003; 73: 193-200.
129. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, Sarbazi N. Serum lipid levels in an Iranian adult population.Tehran Lipid and Glucose Study. Europ J Epidemiol 2003; 18: 311-19.
130. Ordookhani A, Mirmiran P, Hedayati M, Hajipour R, Azizi F: An interim report of the pilot study of screening for congenital hypothyroidism in Tehran and Damavand using cord blood spot samples. Eur J Pediatr 2003; 162: 202-3.
131. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diab Res Clin Pract 2003; 61: 29-37.
132. Hedayati M, Yazdanparast R, Fasihi H, Azizi F: Anti-tumor activity of daphne mucronata extract and its effects on TNF-a receptors and TNF-a release in cultured human monocytes. Pharmaceutical Biology 2003; 41: 194-8.
133. Azizi F. Thyroid function in breast-fed infants is not affected by methimazole-induced materal hypothyroidism: results of a retrospective study. J Endocrinol Invest 2003; 26: 301-4.
134. Ghazi AA, Hadayegh F, Khakpour G, Azizi F, Melby JC. Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia. J Endocrinol Invest 2003; 26: 84-7.
135. Orookhani A, Mirmiran P, Najafi R, Hedayati M, Azizi F: Congenital hypothyroidism in Iran. Indian J Pediatr 2003; 70: 625-8.
136. Azizi F: Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study. J Endocrinol Invest 2003; 26: 301-4.
137. Azizi F: Salt Iodization, Moniyoting, and Evaluation (SIME): an effective replacement for Universal Salt Iodization (USI). Int J Endocrinol Metab 2003; 2: 46-7.
138. Azizi F, Ainy E: Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, Tehran Lipid and Glucose Study. Climacteric 2003; 6: 330-6.
139. Azizi F, Siahkolah B: Ramadan fasting and diabetes mellitus. Arch Iranian Med 2003; 6: 237-42.
140.Azizi F, Siahkolah B: Ramadan fasting and diabetes mellitus. Internal J Ramadan Fast Resea. HTTP//WWW. LABS. NET/AINS/J 98 AR 2. HTM, 1999.
141. Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M: Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003; 26: 703-9.
142.Azizi F: Continuing professional development in the health sector. In: Towards a global health workforce strategy, Ferrinho p & Dal Poz M (eds). ITGP Press, Antwerp, Belgium 2003, 309-409.
143. Azizi F, Bahrainian M, Khamseh M, Khoshniat M: Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Ped Endocrinol Metab 2003; 16: 1239-43.
144. Salarkia N, Hedayati M, Mirmiran P, Kimiagar M, Azizi F: Evaluation of the impact of an iodine supplementation programme on severely iodine-deficient schoolchildren with hypothyroidism. Public Health Nutrition 2003; 6: 529-33.
145. Azizi F, Malik M, Bebars E, Delshad H, Bakir A. Thyroid volumes in schoolchildren of the Emirates.
J Endocrinol Invest 2003; 26: 56-60.
146. Mirmiran P, Hedayati M, Noohi S, Azizi F: The effect of iodized oil administration on the impaired hearing of iodine deficient schoolchildren. Int J Endocrinol Metab 2003; 2: 61-6.
147. Azizi F, Gouya MM, Vazirian P, Dolatshahi P, Habibian S: The diabetes prevention and control programme of the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2003; 9: 1114-1121.
148. Azizi F, Gouya MM, Vazirian P, Dolatshahi P, Habibian S: Screening for tyoe 2 diabetes in the Iranian national programme: a preliminary report. Eastern Mediterranean Health Journal 2003; 9: 1122-1127.
149. Azizi F: Evaluation of the community-oriented medical education in two medical schools in Sudan. Eastern Mediterranean Health Journal 2003; 9: 191-200.
150. Raiszadeh F, Solati M, Etemadi A, Azizi F: Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinology 2004; 60: 75-80.
151. Azizi F, Etemadi A, Hajipoor R, Mortazavi N. Trends of publication in Medical Journals in Iran in the 1990’s. Saudi Med J 2004; 25: S34.
152. Etemadi A, Raiszadeh R, Alaeddini F, Azizi F. Views of Iranian medical journal editors on medical research publication. Saudi Med J 2004; 25: S29-S33.
153. Ghanbarian A, Rashidi A, Madjid M, Azizi F. Blood pressre measures and electocardiogram-defined myocardial infarction in an Iranian population: Tehran Lipid and Glucose Study. J Clinical Hypertension 2004; 6: 71-5.
154. Mirmiran P, Azadbakht L, Esmaill Zadeh A, Azizi F: Dietary diversity score in adolescents – a good indicator of nutritional adequacy of the diet: Tehran Lipid and Glucose. Asia Pacific J Clin Nutr 2004; 13: 56-60.
155. Solati M, Ghanbarian A, Rahmani M, Sarbazi N, Allahverdian S, Azizi F: Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose). Inter J Obes 2004; 28: 706-9.
156. Saadat N, Sheikholeslam R, Azizi F: Impact of iodized oil injection during pregnancy on thyroid function tests of offsprings. Med J Islamic Repub Iran 2004; 17: 277-83.
157. Azizi F: Endocrinology and metabolism in the Islamic Republic of Iran. Archives of Iranian Medicine. Endocrinology & Metabolism 2004; 7: 69-74.
158. Mirmiran P, Esmaillzadeh A, Azizi F: Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis. Europ J Clinl Mutr 2004; 58: 1110-18.
159. Habibi Moeini S, Mirmiran P, Mehrabi Y, Azizi F: Evaluation of different risk factors for early diagnosis of diabetes mellitus. Iran J Med Sci 2004; 29: 21-5.
160. Rezaei-Ghaleh N, Mirbolooki M, Shiva N, Azizi F: Biomedical publications on diabetes mellitus, research gap in developing countries. Int J Endocrinol Metab 2004; 3: 51-6.
161. Mirsaeid Ghazi AA, Rais Zadeh F, Pezeshk P, Azizi F: Seasonal variation of serum 25 hydroxy D3 in residents of Tehran. J Endocrinol Invest 2004; 27: 676-9.
162. Esmaillzadeh A, Mirmiran P, Azizi F: Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthripometric indicator in Tehranian adult men. Inter J of Obes 2004; 28: 1325-32.
163. Ordookhani A, Mirmiran P, Moharamzadeh M, Hedayati M, Azizi F: A high prevalence of consanguineous and severe congenital hypothyroidism in an Iranian population. J Pediatric Endocrinology & Metabolism 2004; 17: 1201-9.
164. Ghaleh NR, Siadat F, Azizi F: Quantitative and qualitative assessment of biomedical publication from Iran, Pakistan and Egypt through their impact factor. J Pak Med Assoc 2004; 54: 528-9.
165. Rezaei-Ghaleh N, Ghanbarian A, Etemadi A, Momenan A, Azizi F: Prevalence of rose angina and ECG-defined coronary heart disease and the concordance between Tehran in diabetic patients: (Tehan Lipid and Glucose Study). Proceedings of the 12th International Congress of Endocrinology Lisbon, Aug. 31-Sept. 4, 2004; 467-71.
166. Kharabsheh S, Belbesi A, Qarqash W, Azizi F: Goiter prevalence and urinary iodine excretion in schoolchildren of Jordan. Int J Vitam Nutr Res 2004; 74: 301-4.
167. Azizi F, Mirmiran P, Azadbakht L: Predictors of cardiovascular risk factors in Tehranian adolescents: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res 2004; 74: 307-12.
168. Azizi F, Sadeghipour H, Siahkolah B, Rezaei-Ghaleh N: Intellectual development of children of mothers who fasted in Ramadan during pregnancy. Int J Vitam Nutr Res 2004; 74: 374-80
169. Azizi F, Salarkia N, Mirmiran P: Timing of the effect of iodine supplementation on intelligence Quotients of schoolchildren. Int J Endocinol Metab 2004; 2: 95-102.
170. Azizi F: Age as a predictor of recurrent hypothyroidism in patients with postpartum thyroid dysfunction. J Endocrinol Invest 2004; 27: 996-1002.
171. Nabipour I, Ghasemi F, Kiai S, Baradar-Jalili R, Azizi F. The mutations of RET proto-oncogene in medullary thyroid carcinoma in Iran. Med J IRI 2004; 18: 95-9.
172. Azizi F, Esmaillzadeh A, Mirmiran P. Obesity and cardiovascular risk factors in Tehranian adults: a population-based cross-sectional study. East Med Health J 2004; 10: 887-97.
173. Azizi F, Mehran L: Experiences in the prevention, Control, and elimination of iodine deficiency disorders: a regional perspective. . East Med Health J 2004; 10: 761-70.
174. Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption and body mass index: An inverse relationship. Int J Obes 2005; 29: 115-21.
175. Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central obesity among Tehranian adults between 1998-1999 and 2001-2002: Tehran Lipid and Glucose Study. Ann Nutr Metab 2005; 49: 3-8.
176. Azuzi F: The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. European J Endocrinol 2005; 153: 367-71.
177. Esmaillzadeh A, Mirmiran P, Azizi F: Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr 2005; 81: 55-63.
178. Azizi F, Esmaillozadeh A, Mirmiran P, Einy E. Is there an independent association between waist-to-hip ratio and cardiovascular risk factor in overweight adnd obese women? Inter J Cardiol 2005; 101: 39-46.
179. Yazdanpanah R, Hedayati M, Azizi F: The effects of the cryde abd tge actuve cinoibebt of dendristekkera kessertuu ib tge Co-cyktyres of Human Monocytes with CCRF-CEM or K562 Cell Lines. Iranian Int. J. Sci. 2005; 6: 1-13.
180. Azizi F, Hedayati M, Rahmani M, Sheikholeslam R, Allahverdian S, Salarkia N. Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005; 28: 23-9.
181. Esmaillzadeh A, Mirmiran P, Azizi F: Whole-grain intake and the metabolic sjndrome: a faworale association in Tehranian adults. Eur J Clin Nutr 2005; 59: 353-362.
182. Azizi F, Esmaillzadeh A, Mirmiran P. Correlates of under-and over-reporting of energy intakie in Tehranians: body mass index and lifestyle- related factors. Asia Pac J Clin Nutr 2005; 14: 55-60.
183. Azadbakht L, Mirmiran P, Shiva N, Azizi F: General obesity and central adiposity in a representative sample of Tehranian adults: Prevalence and determinants. Int J Vitam Nutr Res 2005; 75: 297-304.
184. Shahbazian HB, Sarvghadi F, Azizi F: Ultrasonographic characteristics and follow-up in post-partum thyroiditis. J Endocrinol Invest, 2005; 28: 410-12.
185. Azadbakht L, Mirmiran P, Esmailzadeh A, Azizi T, Azizi F: Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome. Diabetes Care, 2005; 28: 2823-31.
186. Sarvghadi F, Hedayati M, Mehrabi Y, Azizi F: Follow up of patients with postpartum thyroiditis: a population-based study. Endocrine 2005; 27: 279-82.
187. Azizi F, Braverman E. Management of postpartum thyrotoxicosis. Curr Opinion Endocrinol Diab 2005; 12: 471-6.
188. Bazrafshan HR, Mohammadian S, Ordookhani A, Abedini A, Davoudy R, Pearce EN, Hedayati M, Azizi F, Breverman LE. An assessment of urinary and breast-milk iodine concentrations in lactating mothers from gorgan, Iran 2003. Thyroid 2005; 15: 1165-8.
189. Bazrafshan HR, Mohammadian S, Ordookhani A, Farhidmehr F, Hedayati M, Abdolahi N, Azizi F, Braverman LE, Pearce EN. Prevalence of goiter among schoolchildren from Gorgan, Iran, a decade after national iodine supplementation: association with age, gender, and thyroperoxidase antibodies. J Endocrinol Invest 2005; 28: 727-33.
190. Azadbakht L, Mirmiran P, Azizi F: Dietary diversity score is favorably associated with the metabolic syndrome in Tehranian adults. Int J Obes 2005; 29: 1361-7.
191. Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami F: Effect of long-term contininuous methimazole treatment of thyrotoxicosis: comparison with radioiodine. Europ J Clinical Endocrinology 2005; 152: 695-701.
192. Azizi F, Mirmiran P, Hedayati M, Slarkia N, Noohi S: Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. J Endocrinol Invest 2005; 28: 595-8.
193. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 2005; 82: 523-30.
194. Mirmiran P, Azadbakht L, Azizi F: Dietary quality-adherence to the dietary guidelines in Tehranian adolescents: TLGS. Int J Vitam Nutr Res. 2005; 75: 195-200.
195. Azadbakht L, Mirmiran P, Azizi F: Variety scores of food groups contribute to the specific nutrient adequacy in Tehranian men. Eur J clin Nutr 2005; 59: 1233-40.
196. Mirmiran P, Azadbakht L, Azizi F. Dietary quality-adherence to the dietary guidelines in Tehranian adolescents: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res 2005; 75: 195-200.
197. Azadbakht L, Mirmiran P, Hosseini F, Azizi F: Diet quality status of most Tehranian adults needs improvement. Asia Pac J Clin Nutr 2005; 14: 163-8.
198. Esmaillzadeh A, Mirmiran P, Azizi F. Evaluation of waist circumference of predict cardiovascular risk factors in overweight Tehranian population. Int J Vitam Nutr Res 2005; 75: 347-56.
199. Mirsaeid Ghazi AA, Ordookhani A, Pourafkari M, Fallahian M, Bahar A, Hedayati M, Hafizi A, Azizi F: Intrauterine diagnosis and management of fetal goitrous hypothyroidism: a report of an Iranian family with three consecutive pregnancies complicated by fetal goiter. Thyroid. 2005; 15: 1341-7.
200. Saadat N, Salehi P, Emami H Azizi F: The relationship between glucose intolerance and blood pressure, body mass index, and waist to hip ratio in Tehran urban population: Tehran Lipid and Glucose Study. Int J Endocrinol Meta 2005; 3: 37-47.
201. Heydarian P, Azizi F: The frequency of thyroid autoanibodies is higher in the upper bound of normal TSH values. Int J Endocrinol Metab 2005; 3: 10-7.
202. Behjati Ardakani J, Hajipoor R, Valaie F, Azizi F: Thyroid functions in patients with glaucoma. Int J Endocrinol Metab 2005; 3: 99-103.
203. Saadat N, Emami H, Salehi P, Azizi F: Comparison of ADA and wHO criteria in detecting pattern of glucose disorders in a population-vased study: Tehran Lipid and Glucose Study. Endocrinology Metabolism, 2005; 4: 158-64.
204. Shekholeslami F, Ataie L, Hedayati M, Mehrabi Y, Azizi F: Comparison of outcome in radioiodine induced euthyroid and hypothyroid patients. Endocrinology Metabolism, 2005; 4: 174-83.
205. Esmaillzadeh A, Mirmiran P, Azizi F: Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr 2006; 83: 36-46.
206. Azizi F: The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf 2006; 5: 107-16.
207. Esmaillzadeh A, Mirmiran P, Azizi F: Metabolic abnormalities identified by anthropometric measures in elderly men. Am J Clin Nutr 2006; 83: 173.
208. Esmaillzadeh A, Mirmiran P, Azadbakht L, Azizi F,:Prevalence of the hypertriglyceridemic waist phenothype in Iranian adolescents. Am J Prev Med, 2006; 30: 52-8.
209. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F: High prevalence of the metabolic syndrome phenotype in Iranian adolescents. Obesity Research 2006; 14: 377-82.
210. Esmaillzadeh A, Mirmiran P, Azizi F: Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women. Public Health Nutr. 2006; 9: 61-9.
211. Azadbakht L, Mirmiran P, Azizi F: Predictors of cardiovascular risk factors in Tehranian adults: diet and lifestyle. Eastern Mediterranean Health J 2006; 12: 88-97.
212. Daneshpour M, Hedayati M, Azizi F: Hepatic Lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran. European Society Cardiology 2006; 13: 101-3.
213. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dietary diversity score and cardiovascular risk factors in Tehranian adults. Pub Health Nutr 2006; 9: 728-36.
214. Esmaillzadeh A. Mirmiran P, Habibi Moeini S, Azizi F: Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol 2006; 108: 338-45.
215. Ainy E, Ghazi AAM, Azizi F: Changes in calcium, 25 (OH) vitamin D3 and other biochemical factors during pregnancy. J Endocrinol Invest 2006; 29: 303-7.
216. Hadaegh F, Harati H, Ghanbarian A, Azizi F: Association of total cholesterol versus other seryum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Europ J Cardiovas Preven Rehab 2006; 13: 571-7.
217. Mirmiran P, Esmaillzadeh A, Amiri P, Azizi F: Independent and inverse association of hip circumference with metabolic risk factors in Tehranian adult men. Internal J Obesity 2006; 42: 354-7.
218.Hadagh F, Zabetian Z, Harati H, Azizi F: Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in tehranian adult men- a 3.6 year prospective study. Exper Clin Endocrinol Diabet 2006; 114: 310-5.
219. Hosseinpanah F, Ghaffari H, Rambod M, Azizi F: Predicting Isolated Postchallenge Hyperglycemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabe Med 2006; 23: 982-9.
220. Azizi F: Treatment of post-partum thyrotoxicosis. J Endocrinol Invest 2006; 29: 244-7.
221. Mirmiran P, Esmaillzadeh A, Azizi F. Under-reporting of energy intake affects estimates of nutrient intakes.Asia. Pac J Clin Nutr. 2006; 15: 459-64.
222. Mirmiran P, Azadbakht L, Azizi F. Dietary diversity within food groups: an indicator of specific nutrient adequacy in Tehranian women. J Am Coll Nutr. 2006; 25: 354-61.
223. Mirmiran P, Esmaillzadeh A, Azizi F: Diet composition and body mass index in Tehranian adults. Asia Pac J Cli Nutr. 2006; 15: 224-30.
224. Rashidi A, Ghanbarian A, Azizi F, Adler DS. Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor? Southern Medical Association. 2007; 100: 20-26.
225. Mowla A, Dastgheib SA, Chodedri A, Dastouri P. Chronic renal failure and diabetes mellitus: Are they comparable risk factors of coronary artery disease? Southern Medical Association. 2007; 100: 6-7. |